HERZLIYA, Israel and CALGARY, AB, June 13, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries proudly announces the third party publication of a peer-reviewed narrative review in Cureus journal titled "Considering Long-Acting Synthetic Cannabidiol for Chronic Pain: A Narrative Review" (DOI: ). The article discusses the therapeutic potential of long-acting synthetic cannab

This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. Affected Product Device Name Model Number UDI-DI Lot Number IOPS Guidewire ATW-2 H01035 00843152102051 2404-2005 What to Do On April 11, Centerline Biomedical sent all affected customers a letter recommending the following actions: Review your inventory to determine if you have any of

BOLOGNA, Italy, June 13, 2025 /PRNewswire/ -- Datalogic, a global leader in the automatic data capture and factory automation markets, is proud to announce the certification of the Memor 17 Healthcare mobile computer with OncoSafety Remote Control®, the advanced oncology workflow solution developed by B. Braun, a global leader in smart infusion therapy and healthcare technology. This integration combines Datalogic's most advanced healthcare-grade mobile computer with B. Braun's OncoSafety Remote

TORONTO--(BUSINESS WIRE)--Breast Cancer Canada proudly celebrates the federal government’s response to the External Expert Review (EER) of the Canadian Task Force on Preventive Health Care, and the sweeping reforms it recommends to ensure preventive health guidance in Canada is more equitable, expert-informed, and responsive to real-world care. “These systematic changes will save lives,” said Kimberly Carson, CEO of Breast Cancer Canada. “We commend Canada’s Federal Health Minister Marjorie Mich

PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy PolTREG established Immuthera (https://immuthera.bio/) in Delaware to expand its presence in the U.S. market. A Pre-IND application was submitted to the FDA. The Paediatric Committee (PDCO) of the European Medicines Agency issued a positive opinion on PolTREG’s Pediatric Investigation Plan (PIP) for PTG-007 in pre-symptomatic type 1 diabetes (Stage 1). Gdańsk, Poland – 13 JUNE 2025 – PolTREG S.A. (Warsaw

Their tragic deaths highlight the importance of knowing your individual heart health history, as well as the signs and symptoms of genetic heart disease. These tragic deaths highlight the importance of knowing your individual heart health history, as well as the signs and symptoms of genetic heart disease.” — Lisa Salberg, CEO & Founder HCMA DENVILLE, NJ, UNITED STATES, June 13, 2025 / EINPresswire.com / -- The Hypertrophic Cardiomyopathy Association offers our sincere condolences to the family

– Rademikibart significantly improved lung function and asthma control in patients with eosinophilic-driven type 2 asthma – – Rademikibart reduced annualized exacerbations in patients with eosinophilic-driven type 2 asthma – – Data supports ongoing Phase 2 acute exacerbation studies in asthma and COPD; expect to report topline data from both studies in 1H26 – SAN DIEGO, CA, USA I June 13, 2025 I Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma” or the “Company”), a clinical-

Interim analysis shows misetionamide is very well tolerated in combination with gemcitabine; rates of confirmed response, stable disease, and progression-free survival compare favorably with gemcitabine monotherapy BERWYN, PA, USA I June 13, 2025 I Panavance Therapeutics Inc. (“Panavance” or the “Company”), a clinical-stage pharmaceutical company advancing the development of a novel oncology therapeutic intended to improve the outcomes and quality of life for patients, will be attending BIO and

Leading Educational Resource Offers Insights into Sclerotherapy, Laser, and Minimally Invasive Vein Treatments in Dubai Modern varicose vein treatments in Dubai offer safe, minimally invasive options that prioritize both cosmetic results and long-term vascular health.” — Dr. Soroush Sohrabi, Consultant Vascular & Endovascular Surgeon DUBAI, DUBAI, UNITED ARAB EMIRATES, June 13, 2025 / EINPresswire.com / -- Patients in the UAE now have a trusted source for expert guidance on vein conditions, than

Michael Needham, principal at Efficio, a global supply chain procurement consultancy, sat down with MobiHealthNews to discuss how global disruptions due to the proposed and current tariffs are forcing procurement leaders to rethink sourcing strategies, improve supply chain visibility and boost supplier resilience. MobiHealthNews: How have tariffs impacted healthcare technology? Michael Needham: In the near term, it created a lot of uncertainty and indecision for business. So, when businesses ar